Perioperative FLOT(D) With Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Esophageal Cancer

NCT07700420 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Gastro-esophageal Junction (GEJ) Cancer
Esophagus Cancer

Interventions

RADIATION: PULSAR- Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy
DRUG: FLOT (Fluorouracil+Leucovorin+Oxaliplatin+Docetaxel)(D)

Sponsor

University of Texas Southwestern Medical Center